EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-39245 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr3:170406620-170408650 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
CTCFMA0139.1chr3:170408347-170408366CCGCTCCCCCTAGTGGCGG-6.19
FOXC1MA0032.2chr3:170407717-170407728ATATTTACTTA-6.14
Foxq1MA0040.1chr3:170408522-170408533TATTGTTTATA+6.32
MEF2AMA0052.3chr3:170407138-170407150TTTATTTTTAGA-6.07
MEF2CMA0497.1chr3:170407821-170407836AGCTATTTTTATATT-6.16
ONECUT1MA0679.1chr3:170407830-170407844TATATTGATTTTTA-6.01
ONECUT2MA0756.1chr3:170407830-170407844TATATTGATTTTTA-6.22
ONECUT3MA0757.1chr3:170407830-170407844TATATTGATTTTTA-6.47
Number of super-enhancer constituents: 7             
IDCoordinateTissue/cell
SE_36328chr3:170406856-170408606HMEC
SE_38904chr3:170406859-170408497IMR90
SE_45831chr3:170406939-170408571Osteoblasts
SE_51851chr3:170406769-170408466Skeletal_Muscle_Myoblast
SE_55670chr3:170406967-170408997u87
SE_63650chr3:170406948-170408480HSMM
SE_67527chr3:170406967-170408997u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr3170407966170408450
chr3170407977170408137
Number: 1             
IDChromosomeStartEnd
GH03I170688chr3170406465170408889
Enhancer Sequence
ACGAAACAGG CTTTGTGTGA GCAATAAAGC TTTCAATCAT CTGGGTGCAG GCAGGCTGAG 60
TCCGAAAAGA GAGTCAGCGA AGGGAGATAG GGGTGGGGCC GTTTTATAAG ATTTGGGCAG 120
GTAAAGGAAA ATTACAGTCA AAGGGGATTT GTTCTTTGGC GGGCAGGAGT GGGGGTCGCA 180
AGGTGCTCAG TGGGGGTGAT TTTTGAGCCA GGATGAGCCA GGAAAAGGAC TTTCACAAGG 240
TAATGTCATC ACATAAGGCA AGGACCCGCC ATTTTCACTT CTTTTGTGGT GGAATATCAT 300
CAGTTAAGGC AAGGACCAGC CATTTACACT TCTTTTGTGG TGGAATGTCA TCAGTTAAGG 360
TGGGGCAGGG CATATTCACT TCTTTTGTGA TTCTTCAGTT ACTTCAGGCC ATCTGGGCAT 420
ATACATGTAA GTCACAGGGG ATGTGATGGC TTGGCTTGGA CTCAGAGGCC TGACAGGGAC 480
CACACGTGTG CAGTGCACCA CTATGCCCAG CTAAGTTTTT TATTTTTAGA GACGAGGTTT 540
GCTATGTTGC CCAGGCTTGT TTCCAACTCC TGAGCTCAAG TGATCTTCCC ACCTTGGTCT 600
CCCAACGTGC TCGGATTACA GGCATGAACC ATCTTGCCCA GACCCATCCC TTGTTTTTTT 660
ACCTATCAGA TGAACTCTCT TTGTTCCCCA TGTAGAGGCA GAGACTATTA CCAGTGACAT 720
TCCAGTTCAT TTCCTTTTTC AAATTCTTTT CTGGATTGCT TCTCTTCCTT TTAACAAAGA 780
GGGAAAGTAC AGTTCAGTGG GGGCAGGAGA CATGGGCCTA GCAGGCAGTC TGTGCCACCA 840
GGCTGTCAGC ATTAGGACTA AGTCTCTCAC AGACATTCTA GAGCTGCCCC TGGGGCTTTG 900
CCTGCTTTGG CCTCAGGACA AGTGATCAGT GAAGAGCATT CCAAGGAGTT GAGTCTACCC 960
TTCAAGATTC CTTACATATT TTCTGGAAAA AAAAAAAAAA AACACTTGGT GCCTTCAGAT 1020
TCATATGCAA AGGACCTCTG TGCAAATGAA AAGCCTAGTA ATTATCAAGA ATACGTATCA 1080
TAATTTTACA ATTTAAAATA TTTACTTAGC ACTTTAAAGT CTTGAAACAA ATTATTGCCT 1140
TAGGTTGTGT TTTTTAAAAT AGTGAAATAG TTTAGGTATT TAAGTTCTAG CCCTCGCAGT 1200
AAGCTATTTT TATATTGATT TTTATCTGTG CCAAATATGG TGCTAATAGC AAGCAATGGG 1260
GGAGAGTATT ATGTGTCTAT TGACACTGCA TGAAGTATAA GTTCACCATT ATTGTGTCTA 1320
CACTTATAGC ATGGATTTGC CCAGTGCTGC TGAAAGGATG CCCAAGGATG TCTTTCTCCT 1380
GAATGAAGTC TCAGTGGCAT GGCAGTTTGG GAAACGTTGG CCTAAAACAG AAAACGTCTT 1440
CCCAGGTGTG GGGGTGTTAG AGCAGCAGAA CAATGCAAGG AACTTCAAAA CTCCTGATGC 1500
CCAGACTATA CCCTAGTTAG ACCAACTGAG TCAGAATTCC CCGGGGTGGG CGAGACTTGA 1560
GTGAGAACCT ACTGTTAGGA GAAAATATGT CTTCTCTCAT TGTTTCCATT TCCCCCTTGT 1620
TCTGGGCTCT GTGGGCAGGA GAGTGGGAAA AATAAAAAAG AGGATGAAGT GGGGCCTTTA 1680
AAATGTCTTG GAGAATAACC ACCACCACCA CAGGAAGTGC AGGGACCCCG CTCCCCCTAG 1740
TGGCGGTGTG CCGGAGGCAG CTGGAAGTGC CTGGCCGGCC TGGCCGGCCT GGGCGTTATG 1800
TGTGTTAGGA AAGCCGTGTG TCTTCTGCAG GCTTCCTTTT TATAAAATGT GTATTCTATT 1860
TATGCGTATT TATTTAAATT TTATTATGTT TACCTATTTA TTTATTGTTT ATAAATATAT 1920
GCTTTCTGTA TTTTTGTATT TTATGTTTAT ATAAAGGTGT CCACTGTGGA GCTCTCTAAC 1980
ATGTTCTGAG TCTAGAGGAG GCAGGTGAAG GTGAAGGCCA CACGGTGACC 2030